BRIEF-Glaxosmithkline reports 9.3% passive stake in Regulus Therapeutics

Published Wed, Oct 10 2012 12:15 AM EDTUpdated Fri, Sep 13 2013 4:33 PM EDT

Oct 10 (Reuters) - Regulus Therapeutics Inc :

* Glaxosmithkline plc reports 9.3% passive stake in Regulus Therapeutics Inc

1
Millennials are 'quiet vacationing' rather than asking their boss for PTO
2
Bill Gates names his top book recommendations of the summer—and the one that's a 'must-read'
3
Fani Willis and judge presiding over Trump election interference case defeat challengers in election
4
Want to fit in while in Japan? Follow these unusually specific 'life rules' issued by the government
5
31-year-old joined the Air Force at 18—now he has $500,000 saved up to retire in 7 years

View the full site